Kyoung-Je Cho

Title: Kyoung-Je Cho: Innovator in Cancer Treatment

Introduction

Kyoung-Je Cho is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of oncology, particularly in the treatment of non-small cell lung cancer. His innovative approach focuses on utilizing statin-based drugs to combat cancer that has developed resistance to traditional therapies.

Latest Patents

Kyoung-Je Cho holds a patent for the "Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor." This patent describes a pharmaceutical composition that demonstrates therapeutic efficacy against EML4-ALK-positive non-small cell lung cancer, which has acquired resistance to an ALK inhibitor. The patent also outlines a method for treating this specific type of lung cancer and provides guidance for drug selection to determine the appropriateness of administering a statin-based drug to affected patients.

Career Highlights

Throughout his career, Kyoung-Je Cho has worked with reputable organizations, including Jeuk Co., Ltd. and Yonsei University. His work in these institutions has allowed him to advance his research and contribute to the development of effective cancer treatments.

Collaborations

Kyoung-Je Cho has collaborated with esteemed colleagues, including Han Na Kang and Byoung Chul Cho. These partnerships have fostered a collaborative environment that enhances research and innovation in cancer treatment.

Conclusion

Kyoung-Je Cho's contributions to the field of oncology through his innovative patent and collaborative efforts highlight his commitment to improving cancer treatment. His work continues to inspire advancements in medical research and patient care.